about
Glycosyltransferases and non-alcoholic fatty liver diseaseLiver tumors in children with metabolic disordersDiverse roles of the nucleic acid-binding protein KHSRP in cell differentiation and diseaseAntioxidant vitamins in the context of nonalcoholic fatty liver disease in obese children and adolescentsSimple sugar intake and hepatocellular carcinoma: epidemiological and mechanistic insightModulation of hepatic steatosis by dietary fatty acidsEnergy metabolism in the liverCross-talk between the thyroid and liver: a new target for nonalcoholic fatty liver disease treatmentRole of mitochondria in nonalcoholic fatty liver diseaseConjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expressionNIKEI: a new inexpensive and non-invasive scoring system to exclude advanced fibrosis in patients with NAFLDTuberculosis and hepatic steatosis are prevalent liver pathology findings among HIV-infected patients in South AfricaNon-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment.High-frequency ultrasound imaging for longitudinal evaluation of non-alcoholic fatty liver disease progression in mice.Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis.Subclinical abnormal glucose tolerance is a predictor of death in liver cirrhosis.Molecular pathways in non-alcoholic fatty liver disease.Expression of fatty acid synthase in nonalcoholic fatty liver disease.Upregulation of hemoglobin expression by oxidative stress in hepatocytes and its implication in nonalcoholic steatohepatitis.Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease.Management of nonalcoholic fatty liver disease: an evidence-based clinical practice review.Sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD.The impact of weight changes on nonalcoholic Fatty liver disease in adult men with normal weight.Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats.Markers of liver function and inflammatory cytokines modulation by aerobic versus resisted exercise training for nonalcoholic steatohepatitis patients.Correction of liver steatosis by a hydrophobic iminosugar modulating glycosphingolipids metabolism.GLP-1 receptor activation inhibits VLDL production and reverses hepatic steatosis by decreasing hepatic lipogenesis in high-fat-fed APOE*3-Leiden miceAuricularia polytricha aqueous extract supplementation decreases hepatic lipid accumulation and improves antioxidative status in animal model of nonalcoholic fatty liver.KSRP is critical in governing hepatic lipid metabolism through controlling Per2 expression.Hepatic SH2B1 and SH2B2 regulate liver lipid metabolism and VLDL secretion in miceThe effect of berberis vulgaris extract on transaminase activities in non-alcoholic Fatty liver disease.Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis.Diagnosis and evaluation of nonalcoholic fatty liver disease.Lipocalin 13 protein protects against hepatic steatosis by both inhibiting lipogenesis and stimulating fatty acid β-oxidation.Increased expression of zinc finger protein 267 in non-alcoholic fatty liver disease.Physical activity and nutrition attitudes in obese Hispanic children with non-alcoholic steatohepatitis.Quantification of liver, pancreas, kidney, and vertebral body MRI-PDFF in non-alcoholic fatty liver disease.Sex and race differences in the prevalence of fatty liver disease as measured by computed tomography liver attenuation in European American and African American participants of the NHLBI family heart study.The role of metformin in the management of NAFLDPathophysiology after pancreaticoduodenectomy.
P2860
Q26764913-491A8685-129C-4032-9045-C9DE7863BD71Q26770292-C8747B41-3F38-4BC9-B3AE-3BB7FDDE23C9Q26771889-E9706DEC-E305-4099-AEE5-C5915B964161Q26825364-DA5889A8-6D5A-4DA0-B0AC-494EC3136F43Q26864513-65E90B94-6B9A-45AE-AA47-F58E687BDBF5Q26991735-5159D76E-13ED-443A-8B25-9EB920EFDA43Q26996783-CEA4E86B-F3A3-492F-B2B5-1F05BDB76A5CQ27011338-AD6C3456-F565-4E31-977C-886597B01004Q27028142-0D1F8FBC-B5A6-4D9C-9B93-47C6F006668FQ28250778-E6F76C7A-0797-4F1C-BF88-1B5A4D1EC6D4Q28488938-F80CE42A-E162-4E94-961D-1B486F331C66Q28543376-D363B2FE-DCC7-4C7C-A13A-A750EAB945C8Q30434684-D90C47CC-F69B-4765-AB77-6296174E90A5Q30466289-2878EC26-3E55-4374-B2DE-36235CD6375AQ30479092-8CEB5582-093E-424E-B9BA-16A0BDCC5734Q33735381-2635536B-08AE-4EC5-BCCF-18C434E646E5Q33890230-8C9FEF2C-92A7-48F6-8CDE-7E81D10EBA3AQ33962008-9A232670-2267-4368-961B-0F11332E4203Q34023427-5E28BD80-C6A5-44D8-9DF3-BE608141CCB1Q34101705-55DFA99F-123D-43E4-9657-D6FF53BD006CQ34168532-5ABD96BD-3249-44D1-AB47-720DEE962518Q34234946-108F0F30-D0EC-4D27-A649-6CB695BD7BE7Q34318690-6574CD6A-F3F1-493F-B484-63BA7CFDF65CQ34401755-A64BD5FE-8BA0-4D1A-A687-42068EC2A16CQ34405598-E1F5FD17-51BF-4753-95D9-3CBB8306BC0AQ34440771-857EF473-2F64-431E-9A1F-CD46F856DFAAQ34469947-D9866CBE-3B5A-47E0-AAB1-6290B0852B18Q34691776-56690FE5-536B-427B-9859-3F4F30418322Q35014217-2B2F40B9-E463-4C32-B420-7948D4C3CCF5Q35073042-88C0B25B-DBC1-4C63-BBE5-6389C05C8DD1Q35149311-E6FC73A5-588C-4DDB-99FE-908AEAE0B1F9Q35226097-51127B9D-580C-4120-B04E-CF777E63FB96Q35495753-FBE56ED6-5988-47E4-B6C8-C6786A8D3767Q35515576-B8260D42-C64C-47B0-82F3-914B93E1BB58Q35532289-7078CF4E-CF66-4CEE-BFDA-6352DA36D282Q35555722-E6CC6005-F7EA-424F-AD9E-A8F50E719EEDQ35567824-9CDAA036-30EA-4816-A07C-6E4673D4482CQ35600786-974C5A30-ABB5-48E5-928C-8E8B4003EA47Q35614956-23CE5EC5-8628-4B26-8B4B-70A8732AD25FQ35625352-770226FD-FB95-47C2-8E93-BF31412BD379
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nonalcoholic fatty liver disease: a review and update.
@en
Nonalcoholic fatty liver disease: a review and update.
@nl
type
label
Nonalcoholic fatty liver disease: a review and update.
@en
Nonalcoholic fatty liver disease: a review and update.
@nl
prefLabel
Nonalcoholic fatty liver disease: a review and update.
@en
Nonalcoholic fatty liver disease: a review and update.
@nl
P2860
P1476
Nonalcoholic fatty liver disease: a review and update.
@en
P2093
Jeffrey R Lewis
Smruti R Mohanty
P2860
P2888
P304
P356
10.1007/S10620-009-1081-0
P577
2010-01-26T00:00:00Z